Banamine Injectable Solution:

Reduces fever associated with bovine respiratory disease and endotoxemia.

Reduces inflammation associated with endotoxemia.

Helps cattle feel and look better fast.

Banamine Injection (flunixin meglumine) is the only injectable non-steroidal anti-inflammatory approved for use in cattle in the U.S.

Jump Start Recovery

Cattle with bovine respiratory disease (BRD) usually go off feed. Two reasons for this are fever and lung inflammation.

The bacteria that cause BRD produce toxins.

Those toxins cause the fever and lung inflammation associated with BRD.

Those toxins make cattle feel sick and go off feed.

In many cases these circumstances lead to costly chronics and mortalities.

Banamine can change that.

Banamine Relieves Symptoms Fast

A recent survey of producers revealed how quickly cattle improved with Banamine.

98% of the producers said they would consider using Banamine as a routine treatment with their antibiotic.

Restore Performance

Banamine helps the calf feel better and look better. It also helps reduce inflammation and control endotoxemia leading to lung lesions.

Cattle treated with antibiotics plus Banamine have a much lower incidence of lung lesions than cattle treated with antibiotics alone.¹

Research shows that cattle with healthy lungs gain as much as .17 pounds per day more than cattle with lung lesions.²

Over a 180-day feeding period, .17 pounds per day adds up to more than 30 pounds.

Quite simply, cattle with healthy lungs perform better.

How to Add Banamine to Your Treatment Program

Field studies have shown that more than 60% of animals required only one dose.¹

For more information, contact your Intervet/Schering-Plough Animal Health Representative.

1. Data on file at Intervet/Schering-Plough Animal Health.

2. Wittum, TE et al. Relationships among treatment for respiratory tract disease, pulmonary lesions evident at slaughter, and rate of weight gain in feedlot cattle. JAVMA, Vol. 209, No. 4, August 15, 1996.

Intervet/Schering-Plough Animal Health

All rights reserved.